Edition:
United Kingdom

Consun Pharmaceutical Group Ltd (1681.HK)

1681.HK on Hong Kong Stock

8.95HKD
23 May 2018
Change (% chg)

HK$-0.02 (-0.22%)
Prev Close
HK$8.97
Open
HK$8.94
Day's High
HK$9.21
Day's Low
HK$8.83
Volume
3,149,402
Avg. Vol
2,075,416
52-wk High
HK$9.49
52-wk Low
HK$5.44

Chart for

About

Consun Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The pharmaceutical products of the Company include kidney medicines, contrast medium and others. The Company’s subsidiaries include Brilliant Reach Group Limited, Century International Develop... (more)

Overall

Beta: 0.58
Market Cap(Mil.): HK$5,349.71
Shares Outstanding(Mil.): 828.13
Dividend: 0.10
Yield (%): 2.26

Financials

  1681.HK Industry Sector
P/E (TTM): 14.67 30.95 32.75
EPS (TTM): 0.44 -- --
ROI: 20.40 14.84 14.38
ROE: 23.28 16.34 16.07

BRIEF-Consun Pharmaceutical Group FY ‍Profit Attributable RMB396.2 Mln

* ‍PROFIT FOR YEAR ENDED 31 DECEMBER 2017 ATTRIBUTABLE RMB396.2 MILLION, AN INCREASE OF 28.8%​

21 Mar 2018

BRIEF-Consun Pharmaceutical Group Updates On Progress In Application For New Medicine Registration

* UNITS ‍GRANTED "CLINICAL TRIAL APPROVAL" BY CHINA FDA FOR "ASTRAGALI POWDER PELLET", A PIPELINE MEDICINE​ Source text for Eikon: Further company coverage:

15 Mar 2018

Earnings vs. Estimates